Rocket


News + Filings
Transactions



PARMAR KUSH

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/08/2023Entrada Therapeutics, Inc.TRDAGrantStock Option (Right to Buy)16k$14.67$234.7k 06/08/2023
05/17/2023Rallybio CorpRLYBGrantOption (Right to Buy)15.5k$5.64$87.4k 05/17/2023
03/07/2023Rallybio CorpRLYBSaleCommon Stock100k$8.20$820kBy 5AM Ventures V, L.P.03/07/2023
01/03/2023Rallybio CorpRLYBGrantOption (Right to Buy)10.3k$6.19$64k 01/03/2023
12/01/2022Akouos, Inc.AKUSDispositionStock Option (right to buy)16k$4.21$67.4k 11/30/2022
11/30/2022Akouos, Inc.AKUSOtherCommon Stock3.2M$0.00$0See Footnote11/30/2022
11/30/2022Akouos, Inc.AKUSOtherCommon Stock982.5k$0.00$0See Footnote11/30/2022
06/23/2022Akouos, Inc.AKUSGrantStock Option (right to buy)16k$4.21$67.4k 06/23/2022
06/15/2022Homology Medicines, Inc.FIXXGrantOption (Right to Buy)18k$1.88$33.8k 06/15/2022
06/14/2022Vor Biopharma Inc. GrantStock Option (right to buy)16.9k$4.26$72k 06/14/2022
06/03/2022Rallybio CorpRLYBSaleCommon Stock99.7k$12.50$1.2MBy 5AM Ventures V, L.P.06/03/2022
06/03/2022Rallybio CorpRLYBSaleCommon Stock50.3k$12.50$629.1kBy 5AM Opportunities I, L.P.06/03/2022
06/02/2022Entrada Therapeutics, Inc.TRDAGrantStock Option (Right to Buy)11.9k$6.06$72.2k 06/02/2022
05/24/2022Rallybio CorpRLYBGrantOption (Right to Buy)13.4k$12.75$171.4k 05/24/2022
05/23/2022Rallybio CorpRLYBSaleCommon Stock66.4k$13.00$863.8kBy 5AM Ventures V, L.P.05/23/2022
05/23/2022Rallybio CorpRLYBSaleCommon Stock33.6k$13.00$436.2kBy 5AM Opportunities I, L.P.05/23/2022
02/08/2022Rallybio CorpRLYBSaleCommon Stock70.5k$13.05$919.5k5AM Opportunities I, L.P.02/08/2022
02/08/2022Rallybio CorpRLYBSaleCommon Stock139.5k$13.05$1.8M5AM Ventures V, L.P.02/08/2022
01/03/2022Rallybio CorpRLYBGrantOption (Right to Buy)5.8k$10.38$59.9k 01/03/2022
11/16/2021Vor Biopharma Inc. SaleCommon Stock238.9k$15.30$3.7MSee footnote11/16/2021
11/16/2021Vor Biopharma Inc. SaleCommon Stock91.8k$15.30$1.4MSee footnote11/16/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionSeries A Preferred Stock2.4M$0.00$0See Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionSeries A Preferred Stock564.2k$0.00$0See Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionSeries B Preferred Stock254.5k$0.00$0See Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionSeries B Preferred Stock318.1k$0.00$0See Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionCommon Stock254.5k$0.00$0See Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionCommon Stock564.2k$0.00$0See Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionCommon Stock2.4M$0.00$0See Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionCommon Stock318.6k$0.00$0See Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionSeries Seed Preferred Stock318.6k$0.00$0See Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAPurchaseCommon Stock250k$20.00$5MSee Footnote11/02/2021
11/02/2021Entrada Therapeutics, Inc.TRDAConversionCommon Stock318.1k$0.00$0See Footnote11/02/2021
10/28/2021Entrada Therapeutics, Inc.TRDAGrantStock Option (Right to Buy)23.6k$20.00$471k 10/28/2021
08/02/2021Rallybio CorpRLYBPurchaseCommon Stock615.4k$13.00$8M5AM Opportunities I, L.P.07/28/2021
07/28/2021Rallybio CorpRLYBOther (disposition)Series A-1 Preferred Units1.8M$0.00$05AM Ventures V, LP.07/28/2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy